B-cell Lymphoblastic Lymphoma

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma [Phase 2]

  Phase 2 trial update evaluating the combination of Inotuzumab ozogamicin with lower-dose chemotherapy versus standard chemotherapy in adults…

• CLINICAL_TRIALS research · 2025-11-06
  Clinical Trial Update: Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 clinical study evaluating frontline therapy with blinatumomab, inotuzumab ozogamicin, and chemotherapy for B-cell acute lymphoblasti…

• CLINICAL_TRIALS research · 2024-08-28
  Clinical Trial Update: Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma [Phase 1]

  A Phase 1 trial in Belarus is evaluating a pilot CD19-targeted CAR-T cell therapy for children and young adults with relapsed/refractory B-c…

• CLINICAL_TRIALS research · 2024-07-16
  Clinical Trial Update: CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating a CD19 and CD20 bispecific CAR T cell therapy for relapsed or refractory B-cell hematologic malignancies…